Blood Metabolites Point to a Spaceflight Shift in Gut Function
Constipation in orbit has long been treated as an expected nuisance of human spaceflight. New work from the University of Copenhagen, done with NASA, offers a more mechanistic explanation: within weeks of entering microgravity, the astronauts’ gut microbiota appear to shift toward greater protein fermentation, a pattern consistent with slower intestinal transit and reduced fiber availability in the colon.
The study analyzed blood samples from 52 astronauts who spent months aboard the International Space Station. Rather than relying on a narrow panel of preselected compounds, investigators used non-targeted metabolomics to scan broadly for circulating metabolites linked to digestive activity. The approach revealed a consistent pattern across missions and across years, despite the usual biological variability that makes human metabolite studies difficult to interpret.
One sentence captures the core finding: the digestive system in space does not simply slow down, it appears to change its chemistry.
Slower Transit Gives Bacteria More Time to Switch Fuel Sources
Protein fermentation is not unique to spaceflight. On Earth, it can emerge when intestinal contents move too slowly and bacteria exhaust the available fiber, forcing them to break down protein instead. In the space environment, the absence of gravity likely alters peristalsis and slows movement through the gut. With more time in the intestine, microbes have a larger window to shift away from fiber metabolism and toward protein-based substrates.
That biological sequence fits the astronaut data. Joint first author Giorgia La Barbera said the blood samples showed signs that gut bacteria begin fermenting protein more extensively within weeks of arrival in space, and that the change persists until the astronauts return to Earth. Co-author Henrik Roager linked the pattern to slowed passage through the intestines, a mechanism that also offers a plausible explanation for why constipation is so common in microgravity.
This is not just a comfort issue. Prolonged transit changes the microbial output that reaches the bloodstream, and those metabolites can influence more than bowel habits.
Circulating Metabolites Offer Clues Beyond the Colon
The study used blood metabolites as a window into intestinal function. Metabolites are small molecules that reflect diet, metabolism, and microbial activity, and they can reveal what is happening in the gut even when direct sampling is impractical. In this case, the pattern of circulating compounds suggested increased protein fermentation during spaceflight, along with smaller changes related to fish and caffeine consumption.
Those findings matter because microbial byproducts are not confined to the intestine. Lars Ove Dragsted noted that products of protein fermentation have been associated with adverse effects such as kidney damage, reduced ability to focus, and possible mood-related consequences. The gut-brain axis gives that concern biological credibility: what bacteria generate in the bowel can circulate systemically and interact with other organs, including the brain.
The signal is especially relevant in a setting where sleep, workload, circadian rhythm, and radiation already stress human physiology.
Why the Astronaut Cohort Was So Informative
Spaceflight studies usually struggle with tiny sample sizes and heterogeneous exposure patterns. This cohort had a different strength. The astronauts came from 52 different individuals, flown on different missions across many years, and the samples were drawn from three separate International Space Station studies. Jan Stanstrup said the diversity of the cohort made it remarkable that the analysis still produced such a clear, consistent pattern of increased protein fermentation.
That consistency is important. Human metabolism varies widely from person to person, so a strong repeated signal across multiple astronauts makes the result more persuasive than a single isolated finding would have been. Even with small amounts of blood available, the investigators were able to extract additional information from the stored samples and deepen the metabolic readout.
The work also illustrates how much information can be recovered when untargeted analytics are applied carefully to rare clinical material.
Fiber, Prebiotics, and Peristalsis as Countermeasures
The practical implications are straightforward for future exploration missions. If slower transit drives microbial protein fermentation, then countermeasures should aim to restore movement through the gut and preserve a more fiber-dependent microbiome. The investigators point to increasing dietary fiber, using prebiotics, and other treatments that support peristalsis and shorten gut transit time.
In clinical terms, the target is not merely symptom relief. The goal is to prevent the microbial ecosystem from shifting into a less favorable metabolic state. By keeping intestinal contents moving, astronauts may spend less time in a fermentative environment that favors protein breakdown and the metabolites that follow.
Longer journeys to the Moon and Mars raise the stakes. Crews traveling far beyond low-Earth orbit will spend far more time in microgravity than astronauts on the International Space Station, so even small physiologic changes could accumulate into larger operational problems over months.
Bedridden Patients May Share a Similar Biology
The relevance of the findings extends well beyond space medicine. People confined to bed for long periods also develop constipation, and the same basic mechanism may be at work: slowed intestinal motion, altered microbial metabolism, and increased protein fermentation. Dragsted suggested that this knowledge could help clinicians think differently about bedridden patients, whose bowel symptoms may not be merely inconvenient but biologically active.
There is a clear bedside implication here. Constipation in immobile patients may carry a microbial signature that affects more than stool frequency. If transit slows enough, the gut environment may shift toward the same chemistry seen in orbit, with possible downstream effects on health and cognition.
The work does not prove that every astronaut’s constipation is caused by the same pathway, and it does not establish which countermeasure will work best. It does, however, define a plausible metabolic chain from microgravity to slower transit to microbial protein fermentation, and that chain gives space medicine a concrete target for future trials.
For Mars missions, that may be the difference between treating constipation as an inconvenience and treating it as a preventable physiologic stressor.